BIS
ProShares UltraShort NASDAQ BiotechnologystockNASDAQETF
The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index®. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 10.16 | 2026-11-10 | +10.58% | -1.558 |
| 1M | 12.09 | 2026-10-16 | -7.05% | -2.191 |
| 3M | 12.29 | 2026-08-17 | -8.56% | -2.132 |
| 6M | 9.13 | 2026-05-18 | +23.06% | -1.514 |
| 1Y | 10.07 | 2025-11-17 | +11.57% | -1.740 |
| 2Y | 17.77 | 2024-11-18 | -36.77% | — |
| 5Y | 19.85 | 2021-11-17 | -43.40% | -1.621 |
ProShares UltraShort NASDAQ Biotechnology (NASDAQ:BIS) stock price today is $11.24, and today's volume is 2,885. BIS is up 1.133% today. The 30 day average volume is 11,384. BIS market cap is $1.86M with 165,520 shares outstanding.
